Orange Book product · Generic (ANDA)
PARICALCITOL
PARICALCITOL
At a glance
Jun 24, 2014
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 24, 2014
12 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
PARICALCITOL
Strength
1MCG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 091412
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PARICALCITOL
- 2016PARICALCITOLBrand (NDA)
NDA 207174 · ACCORD HLTHCARE
- 2014PARICALCITOLBrand (NDA)
NDA 205917 · HIKMA PHARMS
- 2014PARICALCITOLBrand (NDA)
NDA 201657 · HOSPIRA
- 2005ZEMPLARBrand (NDA)
NDA 021606 · ABBVIE
- 2000ZEMPLARBrand (NDA)
NDA 020819 · ABBVIE
- 2018PARICALCITOLGeneric (ANDA)
ANDA 205982 · EUGIA PHARMA
- 2017PARICALCITOLGeneric (ANDA)
ANDA 203897 · RISING
- 2017PARICALCITOLGeneric (ANDA)
ANDA 207692 · EPIC PHARMA LLC
- 2017PARICALCITOLGeneric (ANDA)
ANDA 206699 · AMNEAL PHARMS CO
- 2016PARICALCITOLGeneric (ANDA)
ANDA 204948 · MARKSANS PHARMA
- 2016PARICALCITOLGeneric (ANDA)
ANDA 204910 · CAPLIN
- 2016PARICALCITOLGeneric (ANDA)
ANDA 206710 · LOTUS PHARM CO LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
